Showing results (2041-2050 of 4,133) with videos related to
Sort By:
Pageof 414
Developmental Cell|March 18, 2009
Cadherin adhesion, tissue tension, and noncanonical Wnt signaling regulate fibronectin matrix organizationBette J Dzamba, Karoly R Jakab, Mungo Marsden, et al.International Journal of Surgery (London, England)|June 23, 2009
Polyarteritis nodosa of the breast: presentation and managementHaitham Hassan Khalil, Jo Marsden, Nuzhat Akbar, et al.The Journal of Biological Chemistry|June 25, 1990
Terbium luminescence in synthetic peptide loops from calcium-binding proteins with different energy donorsJ P MacManus, C W Hogue, B J Marsden, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 28, 2014
Picolinamides as effective ligands for copper-catalysed aryl ether formation: structure-activity relationships, substrate scope and mechanistic investigationsCarlo Sambiagio, Rachel H Munday, Stephen P Marsden, et al.Life Sciences in Space Research|April 29, 2026
Bacillus subtilis endospore integrity and viability on simulated Martian regolith in rotational UVC radiation exposuresGregory M Davis, Jonathan Horner, Andrew R Greenhill, et al.Brain : a Journal of Neurology|April 1, 1996
Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UKO C Cockerell, J Rothwell, P D Thompson, et al.Neuropharmacology|June 1, 1984
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to ratsK Murugaiah, S Fleminger, M D Hall, et al.Clinical Neuropathology|January 1, 1982
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL)H H Goebel, H Braak, D Seidel, et al.Clinical Neuropharmacology|February 1, 1989
The antiparkinsonian activity of CQA 206-291, a new D2 dopamine receptor agonistJ A Temlett, N P Quinn, C D Marsden, et al.Reviews of Infectious Diseases|March 1, 1988
Role of drug-abuse treatment in limiting the spread of AIDSR L Hubbard, M E Marsden, E Cavanaugh, et al.Pageof 414